UK markets close in 7 hours 52 minutes

Adverum Biotechnologies, Inc. (0HA3.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
8.61+0.83 (+10.67%)
As of 07:14PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.06
52-week change 3113.25%
S&P500 52-week change 323.28%
52-week high 32.95
52-week low 30.00
50-day moving average 31.51
200-day moving average 31.34

Share statistics

Avg vol (3-month) 327.08k
Avg vol (10-day) 38.04k
Shares outstanding 562.87M
Implied shares outstanding 6N/A
Float 810.61M
% held by insiders 11.20%
% held by institutions 199.16%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.1:1
Last split date 321 Mar 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-27.69%
Return on equity (ttm)-66.40%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -115.32M
Net income avi to common (ttm)-112.9M
Diluted EPS (ttm)-1.58
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)193.33M
Total cash per share (mrq)9.31
Total debt (mrq)74.48M
Total debt/equity (mrq)40.86%
Current ratio (mrq)9.24
Book value per share (mrq)8.78

Cash flow statement

Operating cash flow (ttm)-91.73M
Levered free cash flow (ttm)-64.19M